Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

East Anglian Air Ambulance proves rapid pre-hospital blood test can diagnose brain bleeds in minutes (opens in a new tab)

news-medical.net · 2026-11-04

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One key claim is not backed by the study. 2 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 1 not supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Two claims go beyond the study. One overstates it and one isn't supported at all. Two claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 1 not supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not supportedThe charity says it has been trialing the technology in a US-first for air ambulances as part of its BRAIN-FIRST program.View evidenceHide evidence

As statedUS-first for air ambulances

Why this verdict

The paper profile supports that a UK physician-paramedic helicopter emergency medical service conducted a prehospital diagnostic study using the technology. It does not support the claim that the trial was a 'US-first for air ambulances' or that it was conducted as part of a BRAIN-FIRST program; those programmatic and first-in-class assertions are not present in the abstract profile, and the 'US-first' wording is not aligned with the UK setting described.

1

Study evidence

Prehospital whole-blood GFAP measured on the i-STAT Alinity had very high sensitivity and strong discrimination for detecting intracranial hemorrhage in this cohort.Sensitivity 97.0% (95% CI 84.2%–99.9%); AUC 0.94 (95% CI 0.87–0.99).

“This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026.”
Claim 2 of 5OverstatedEast Anglian Air Ambulance says a pre-hospital blood test can identify patients with bleeding on the brain within minutes.View evidenceHide evidence

As statedwithin minutes

Why this verdict

The abstract-level paper evidence supports a prehospital diagnostic-accuracy study of whole-blood GFAP and UCH-L1 testing on the i-STAT Alinity for detecting intracranial hemorrhage against CT, with high sensitivity for GFAP and 100% sensitivity for a combined biomarker approach in the studied cohort. However, the headline-level framing that a blood test 'can identify' bleeding on the brain within minutes is broader and more definitive than the abstract evidence: the cohort was selected, small, and limited to adults with acute nontraumatic coma undergoing prehospital RSI, and CT remained the reference standard. The exact 'within minutes' timing is also not established in the supplied abstract profile. The headline therefore outruns the more caveated body framing.

1

Study evidence

Prehospital whole-blood GFAP measured on the i-STAT Alinity had very high sensitivity and strong discrimination for detecting intracranial hemorrhage in this cohort.Sensitivity 97.0% (95% CI 84.2%–99.9%); AUC 0.94 (95% CI 0.87–0.99).

“This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026.”
2

Study evidence

A combined prehospital GFAP and UCH-L1 biomarker approach yielded 100.0% sensitivity (95% CI, 89.4%-100.0%) and 100.0% negative predictive value (95% CI, 47.8%-100.0%) for detection of intracranial hemorrhage versus head CT in a cohort of 65 patients with acute nontraumatic coma.Sensitivity 100.0% (95% CI, 89.4%-100.0%); NPV 100.0% (95% CI, 47.8%-100.0%)

“A combined biomarker approach achieved 100.0% sensitivity (95% CI, 89.4%-100.0%) and a negative predictive value of 100.0%”
Claim 3 of 5Not coveredThe test uses a handheld i-STAT Alinity analyzer to measure the brain biomarkers GFAP and UCH-L1 from a small blood sample, with results available in minutes.View evidenceHide evidence

As statedresults available in minutes

Why this verdict

The abstract profile supports that prehospital whole-blood point-of-care GFAP and UCH-L1 testing was performed using the i-STAT Alinity analyzer. However, the supplied abstract-level profile does not verify the 'small blood sample' phrasing or the exact turnaround claim that results are available 'in minutes.' Those operational details may require full-text or device-level evidence beyond the supplied abstract profile.

1

Study evidence

Prehospital whole-blood GFAP measured on the i-STAT Alinity had very high sensitivity and strong discrimination for detecting intracranial hemorrhage in this cohort.Sensitivity 97.0% (95% CI 84.2%–99.9%); AUC 0.94 (95% CI 0.87–0.99).

“This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026.”
Claim 4 of 5Not coveredEast Anglian Air Ambulance says it is now working with other UK and international ambulance services to expand evaluation of BRAIN-FIRST and has deployed the test with more than 200 patients with suspected serious brain injury.View evidenceHide evidence

As statedmore than 200 patients

Why this verdict

The abstract profile says further prospective external validation is needed, but it does not verify that East Anglian Air Ambulance is now working with other UK and international ambulance services, nor that the test has been deployed in more than 200 patients. The paper profile's analytic cohort was 65 patients, so the >200-patient rollout/evaluation claim is not established at the supplied evidence depth.

1

Study evidence

Prehospital whole-blood GFAP measured on the i-STAT Alinity had very high sensitivity and strong discrimination for detecting intracranial hemorrhage in this cohort.Sensitivity 97.0% (95% CI 84.2%–99.9%); AUC 0.94 (95% CI 0.87–0.99).

“This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026.”
2

Study evidence

A combined prehospital GFAP and UCH-L1 biomarker approach yielded 100.0% sensitivity (95% CI, 89.4%-100.0%) and 100.0% negative predictive value (95% CI, 47.8%-100.0%) for detection of intracranial hemorrhage versus head CT in a cohort of 65 patients with acute nontraumatic coma.Sensitivity 100.0% (95% CI, 89.4%-100.0%); NPV 100.0% (95% CI, 47.8%-100.0%)

“A combined biomarker approach achieved 100.0% sensitivity (95% CI, 89.4%-100.0%) and a negative predictive value of 100.0%”
Claim 5 of 5SupportedFindings from the first cohort of patients treated with the analyzer showed the test correctly identified every intracranial hemorrhage that occurred, without missing a single case.View evidenceHide evidence

As statedevery instance ... without missing a single case

Why this verdict

The abstract profile reports that the combined GFAP+UCH-L1 biomarker approach achieved 100.0% sensitivity and 100.0% negative predictive value for ICH detection in the cohort, which supports the story's statement that no intracranial hemorrhage cases were missed in the first cohort. The support is specifically for the combined biomarker approach in a selected cohort of 65 patients, with wide uncertainty for NPV and a need for external validation.

1

Study evidence

A combined prehospital GFAP and UCH-L1 biomarker approach yielded 100.0% sensitivity (95% CI, 89.4%-100.0%) and 100.0% negative predictive value (95% CI, 47.8%-100.0%) for detection of intracranial hemorrhage versus head CT in a cohort of 65 patients with acute nontraumatic coma.Sensitivity 100.0% (95% CI, 89.4%-100.0%); NPV 100.0% (95% CI, 47.8%-100.0%)

“A combined biomarker approach achieved 100.0% sensitivity (95% CI, 89.4%-100.0%) and a negative predictive value of 100.0%”
2

Study evidence

Prehospital whole-blood GFAP measured on the i-STAT Alinity had very high sensitivity and strong discrimination for detecting intracranial hemorrhage in this cohort.Sensitivity 97.0% (95% CI 84.2%–99.9%); AUC 0.94 (95% CI 0.87–0.99).

“This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The studied population was narrowly selected: adults with acute nontraumatic coma, GCS ≤12, undergoing prehospital rapid sequence induction with clinical suspicion of ICH.

    The story frames the test more generally for suspected serious brain injury or bleeding on the brain, but it does not convey the restrictive enrollment criteria. This is interpretation-changing because diagnostic performance may not generalize to broader prehospital populations.

    From Prehospital diagnostic accuracy study; consecutive cohort

  • The primary analytic cohort was modest in size: 65 patients, with 33 cases of ICH and high ICH prevalence of 50.8%.

    The story describes a first cohort and mentions that larger, more diverse populations need evaluation, but it does not report the cohort size or high prevalence, both of which affect precision and predictive values.

    From Prehospital diagnostic accuracy study; consecutive cohort; Prehospital diagnostic accuracy study; combined biomarker ana

  • GFAP alone showed very high but not perfect sensitivity: 97.0% with AUC 0.94.

    The story emphasizes that the test missed no hemorrhages, but the abstract profile distinguishes GFAP alone from the combined biomarker approach. GFAP alone was not reported as 100% sensitive.

    From Prehospital diagnostic accuracy study; consecutive cohort

  • UCH-L1 alone performed worse, with sensitivity 78.8% and specificity 18.8%.

    The story says the test measures UCH-L1 but does not mention that UCH-L1 had limited standalone diagnostic performance in the cohort.

    From Prehospital diagnostic accuracy study; consecutive cohort

3 things the story did carry across
  • The paper is a diagnostic-accuracy study comparing prehospital whole-blood GFAP and UCH-L1 testing with hospital CT as the reference standard for intracranial hemorrhage.
  • The combined GFAP+UCH-L1 approach achieved 100.0% sensitivity and 100.0% negative predictive value in this cohort.
  • The authors state that further prospective external validation is required to establish clinical utility for triage, treatment decisions, and patient outcomes.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEvaluate diagnostic accuracy of prehospital whole-blood point-of-care GFAP (and UCH-L1) for detecting intracranial hemorrhage (ICH) in adults with acute nontraumatic coma undergoing prehospital RSI, using CT as reference standard.Prehospital diagnostic accuracy study; consecutive cohortExpand

In plain English

Diagnostic accuracy study of prehospital whole-blood point-of-care GFAP and UCH-L1 (i-STAT Alinity) in a consecutive cohort of adults with acute nontraumatic coma (GCS ≤12) undergoing prehospital rapid sequence induction, using hospital CT as the reference standard; GFAP showed very high sensitivity and discriminatory ability for intracranial hemorrhage (ICH), UCH-L1 performed worse, and a combined biomarker approach achieved complete sensitivity and NPV in this cohort.

Key findings

  • Prehospital whole-blood GFAP measured on the i-STAT Alinity had very high sensitivity and strong discrimination for detecting intracranial hemorrhage in this cohort.Sensitivity 97.0% (95% CI 84.2%–99.9%); AUC 0.94 (95% CI 0.87–0.99).
  • Prehospital UCH-L1 showed lower sensitivity and poor specificity with limited discriminatory performance for ICH in this cohort.Sensitivity 78.8% (95% CI 61.1%–91.0%); Specificity 18.8% (95% CI 7.2%–36.4%).
“This diagnostic study used data collected by a UK physician-paramedic helicopter emergency medical service between January 1, 2025, and April 30, 2026.”
What this piece can’t prove
  • Single EMS (UK physician-paramedic helicopter) consecutive cohort over specified timeframe; may limit external generalizability.
  • Modest sample size (n = 65) with high observed ICH prevalence (50.8%), which affects predictive values and precision of estimates (wide CIs for some metrics).
  • Cohort restricted to patients undergoing prehospital rapid sequence induction with clinical suspicion of ICH; results may not apply to broader prehospital or less-selected populations.
  • Abstract does not provide timing of biomarker sampling relative to symptom onset in detail; timing could influence biomarker levels and diagnostic performance.
  • Authors note the need for further prospective external validation to determine impacts on triage, treatment decisions, and patient outcomes.
2human in vivoAssess whether combining GFAP and UCH-L1 improves diagnostic performance (e.g., sensitivity/NPV) vs either biomarker alone for ICH detection.Prehospital diagnostic accuracy study; combined biomarker analysisExpand

In plain English

In a consecutive prehospital cohort of adults with acute nontraumatic coma (n=65) who underwent point-of-care whole-blood testing, a combined GFAP+UCH-L1 biomarker rule achieved 100.0% sensitivity (95% CI, 89.4%-100.0%) and a negative predictive value of 100.0% for detection of intracranial hemorrhage (reference: head CT). The abstract reports this combined result alongside single-marker performance (GFAP high sensitivity and AUC; UCH-L1 lower sensitivity and specificity). The abstract does not specify the exact combination rule or thresholding approach.

Key findings

  • A combined prehospital GFAP and UCH-L1 biomarker approach yielded 100.0% sensitivity (95% CI, 89.4%-100.0%) and 100.0% negative predictive value (95% CI, 47.8%-100.0%) for detection of intracranial hemorrhage versus head CT in a cohort of 65 patients with acute nontraumatic coma.Sensitivity 100.0% (95% CI, 89.4%-100.0%); NPV 100.0% (95% CI, 47.8%-100.0%)
“A combined biomarker approach achieved 100.0% sensitivity (95% CI, 89.4%-100.0%) and a negative predictive value of 100.0%”
What this piece can’t prove
  • Small single-cohort sample reported in abstract (n=65) with ICH in 33 patients; limited detail in abstract about combination rule specification or pre-specification.
  • Abstract does not report how the combined biomarker rule was constructed or validated (no details on thresholds, weighting, or internal validation presented in abstract).
  • Authors note need for prospective external validation to establish clinical utility for triage and outcomes.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

GFAP point-of-care measurement for prehospital diagnosis of intracranial hemorrhage in acute coma

Critical Care · 2024 · Crossref

Source (opens in a new tab)
Candidate

Comparison of GFAP and UCH-L1 Measurements Using Two Automated Immunoassays (i-STAT® and Alinity®) for the Management of Patients with Mild Traumatic Brain Injury: Preliminary Results from a French Single-Center Approach

International Journal of Molecular Sciences · 2024 · Crossref

Tessa (opens in a new tab)Source (opens in a new tab)

And 9 more candidates considered.